CONFERENCE HIGHLIGHTS |
Dermatology can be the target of some unnecessarily negative attitudes from other medical specialties regarding revenue. But some "questionable behavior" by some in the specialty should cause others to more closely scrutinize what procedures they are selecting to perform, according to the incoming president of the American Academy of Dermatology. Read more |
Biologic drugs are being extensively explored in medicine, but their use in pediatric patients remains uncharted territory, according to an expert who spoke at the 72nd Annual Meeting of the American Academy of Dermatology. Read more |
When presented with a patient suffering from itching, dermatologists should consider treatments other than topical and oral medications, according to an expert who spoke at the 72nd Annual Meeting of the American Academy of Dermatology. Read more |
When addressing onychomycosis caused by cosmetic procedures, says Zoe D. Draelos, M.D., cuticle removal represents a key culprit. Dr. Draelos spoke about onychomycosis treatment options at the 72nd Annual Meeting of the American Academy of Dermatology. Read more |
In the search for rosacea treatments, topical ivermectin 1 percent cream met its safety endpoints in two pivotal trials that included a total of 910 actively treated subjects, Galderma announced at the 72nd Annual Meeting of the American Academy of Dermatology. Read more |
  |